nervous system
• progressive reduction from age 1 month
|
• vacuolization at age 1 month
|
• vacuolization at age 1 month
|
• at age P16, progressively thinning
|
• at age P16
|
• progressive reduction in thickness from age 1 month
• progressive increase in apoptotic (caspase 3 positive) cells
|
• progressive loss of rod function
|
vision/eye
N |
• normal retina vascularization
• normal retinal pigment epithelium morphology at age 1 month
• normal photoreceptor inner segment mitochondria number and morphology at age 1 month
|
• numerous small white foci
|
• progressive reduction from age 1 month
|
• vacuolization at age 1 month
|
• vacuolization at age 1 month
|
• at age P16, progressively thinning
|
• at age P16
|
• progressive reduction in thickness from age 1 month
• progressive increase in apoptotic (caspase 3 positive) cells
|
• progressive loss of rod function
|
• progressive reduction from age 1 month
• multi-focal reduction in thickness to 2-4 (from 10-12 wildtype) rows at age 3 months
|
• pyknotic cells
|
• with scotopic and photopic ERG at age 3 months
|
• with scotopic and photopic ERG at age 3 months
|
mortality/aging
• mice die at about 9 weeks instead of at 3 weeks as in Ptpn6me homozygotes
• death is due to a progressive and fatal autoimmune syndrome
|
immune system
• prothymocytes from mutant mice do not proliferate or differentiate due to a defect in activity of intrathymic accessory cells derived from bone marrow
|
• lambda1 and lambda2, 3 B cells are reduced 14- and 4-fold, respectively, in the spleen and 5.9- and 2.2-fold, respectively, in the bone marrow compared to B cell numbers in wild-type mice
|
• a result of a rapid expansion of the plasma cell population
|
• atypical plasma or Mott cells with Russell bodies comprising crystallized immunoglobulin occur in lymphoid tissue
|
• due to a factor in serum of mutant mice that increases cell maturation by three orders of magnitude
|
• uncontrolled levels
|
• mutant mice display a decreased response to T-cell mitogens
• interleukin 2 was unable to restore proliferation response in splenic cultures
|
• resembles rheumatoid arthritis
• immunosuppressant drugs inhibit arthritic symptoms, but non-steroid anti-inflammatory drugs do not
|
• reactions in the paws consist mainly of polymorphonuclear and mononuclear cell infiltration in the subcutaneous tissue extending to the periosteum and joint
• paws become deformed causing progressive problems walking
|
• pneumonitis progression is slower than in Ptpn6me homozygotes but still causes death
|
respiratory system
• pneumonitis progression is slower than in Ptpn6me homozygotes but still causes death
|
growth/size/body
hematopoietic system
• prothymocytes from mutant mice do not proliferate or differentiate due to a defect in activity of intrathymic accessory cells derived from bone marrow
|
• lambda1 and lambda2, 3 B cells are reduced 14- and 4-fold, respectively, in the spleen and 5.9- and 2.2-fold, respectively, in the bone marrow compared to B cell numbers in wild-type mice
|
• a result of a rapid expansion of the plasma cell population
|
• atypical plasma or Mott cells with Russell bodies comprising crystallized immunoglobulin occur in lymphoid tissue
|
• due to a factor in serum of mutant mice that increases cell maturation by three orders of magnitude
|
• uncontrolled levels
|
• mutant mice display a decreased response to T-cell mitogens
• interleukin 2 was unable to restore proliferation response in splenic cultures
|
pigmentation
• at 3-4 days of age mice have focal depigmentation of the skin
|
skeleton
integument
• patchy absence of hair follows focal skin depigmentation giving the coat an uneven or motheaten appearance
|
• necrotic lesions can develop on paws, tail and ears
|
• at 3-4 days of age mice have focal depigmentation of the skin
|
endocrine/exocrine glands
• prothymocytes from mutant mice do not proliferate or differentiate due to a defect in activity of intrathymic accessory cells derived from bone marrow
|